{"id":7870,"date":"2020-01-14T03:05:58","date_gmt":"2020-01-14T03:05:58","guid":{"rendered":"http:\/\/timeline-germany.de\/wp-content\/uploads\/2020\/01\/bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren.jpg"},"modified":"2020-01-14T03:05:58","modified_gmt":"2020-01-14T03:05:58","slug":"bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren-2","status":"inherit","type":"attachment","link":"https:\/\/timeline-germany.de\/tr\/bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren-2","title":{"rendered":"bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren"},"author":0,"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"colormag_page_container_layout":"default_layout","colormag_page_sidebar_layout":"default_layout"},"class_list":["post-7870","attachment","type-attachment","status-inherit","hentry"],"aioseo_notices":[],"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/timeline-germany.de\/wp-content\/uploads\/2020\/01\/bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren.jpg'><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"75\" src=\"https:\/\/timeline-germany.de\/wp-content\/uploads\/2020\/01\/bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren-300x75.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/timeline-germany.de\/wp-content\/uploads\/2020\/01\/bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren-300x75.jpg 300w, https:\/\/timeline-germany.de\/wp-content\/uploads\/2020\/01\/bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren.jpg 761w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n"},"caption":{"rendered":""},"alt_text":"","media_type":"image","mime_type":"image\/jpeg","media_details":{"width":761,"height":190,"file":"2020\/01\/bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren.jpg","sizes":{"thumbnail":{"file":"bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren-150x150.jpg","width":150,"height":150,"mime_type":"image\/jpeg","source_url":"https:\/\/timeline-germany.de\/wp-content\/uploads\/2020\/01\/bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren-150x150.jpg"},"medium":{"file":"bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren-300x75.jpg","width":300,"height":75,"mime_type":"image\/jpeg","source_url":"https:\/\/timeline-germany.de\/wp-content\/uploads\/2020\/01\/bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren-300x75.jpg"},"colormag-highlighted-post":{"file":"bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren-392x190.jpg","width":392,"height":190,"mime_type":"image\/jpeg","source_url":"https:\/\/timeline-germany.de\/wp-content\/uploads\/2020\/01\/bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren-392x190.jpg"},"colormag-featured-post-medium":{"file":"bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren-390x190.jpg","width":390,"height":190,"mime_type":"image\/jpeg","source_url":"https:\/\/timeline-germany.de\/wp-content\/uploads\/2020\/01\/bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren-390x190.jpg"},"colormag-featured-post-small":{"file":"bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren-130x90.jpg","width":130,"height":90,"mime_type":"image\/jpeg","source_url":"https:\/\/timeline-germany.de\/wp-content\/uploads\/2020\/01\/bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren-130x90.jpg"},"full":{"file":"bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren.jpg","width":761,"height":190,"mime_type":"image\/jpeg","source_url":"https:\/\/timeline-germany.de\/wp-content\/uploads\/2020\/01\/bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren.jpg"}},"image_meta":{"aperture":"0","credit":"bluebird bio","camera":"","caption":"bluebird bio pr\u00e4sentiert auf der 60. Jahrestagung der American Society of Hematology aktualisierte Daten aus klinischen Studien zur Gentherapie mit LentiGlobin. Die klinischen Programme der bluebird bio Gentherapien umfassen Studien zur Behandlung der zerebralen Adrenoleukodystrophie, der transfusionsabh\u00e4ngigen \u00df-Thalass\u00e4mie und der Sichelzellkrankheit. Weiterer Text \u00fcber ots und www.presseportal.de\/nr\/133038 \/ Die Verwendung dieses Bildes ist f\u00fcr redaktionelle Zwecke honorarfrei. Ver\u00f6ffentlichung bitte unter Quellenangabe: \"obs\/bluebird bio\"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"bluebird bio pr\u00e4sentiert auf der 60. Jahrestagung","orientation":"0","keywords":["Gesundheit","Medizin","Studie","Genetik","Forschung","\u00df-Thalass\u00e4mie","Pharmaindustrie"]}},"post":null,"source_url":"https:\/\/timeline-germany.de\/wp-content\/uploads\/2020\/01\/bluebird-bio-startet-in-deutschland-mit-der-weltweit-ersten-markteinfuehrung-der-gentherapie-zynteglotm-autologe-cd34-zellen-die-fuer-das-ssa-t87q-globin-gen-kodieren.jpg","_links":{"self":[{"href":"https:\/\/timeline-germany.de\/tr\/wp-json\/wp\/v2\/media\/7870","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/timeline-germany.de\/tr\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/timeline-germany.de\/tr\/wp-json\/wp\/v2\/types\/attachment"}],"replies":[{"embeddable":true,"href":"https:\/\/timeline-germany.de\/tr\/wp-json\/wp\/v2\/comments?post=7870"}]}}